- Home
- ALTO vs WHWK Comparison
ALTO vs WHWK Comparison
Compare ALTO & WHWK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALTO
- WHWK
- Stock Information
- Founded
- ALTO 2003
- WHWK 2007
- Country
- ALTO United States
- WHWK United States
- Employees
- ALTO N/A
- WHWK N/A
- Industry
- ALTO Major Chemicals
- WHWK Biotechnology: Pharmaceutical Preparations
- Sector
- ALTO Industrials
- WHWK Health Care
- Exchange
- ALTO Nasdaq
- WHWK Nasdaq
- Market Cap
- ALTO 95.7M
- WHWK 82.4M
- IPO Year
- ALTO N/A
- WHWK N/A
- Fundamental
- Price
- ALTO $1.06
- WHWK $1.74
- Analyst Decision
- ALTO Strong Buy
- WHWK
- Analyst Count
- ALTO 1
- WHWK 0
- Target Price
- ALTO $5.50
- WHWK N/A
- AVG Volume (30 Days)
- ALTO 241.3K
- WHWK 100.5K
- Earning Date
- ALTO 08-06-2025
- WHWK 08-07-2025
- Dividend Yield
- ALTO N/A
- WHWK N/A
- EPS Growth
- ALTO N/A
- WHWK N/A
- EPS
- ALTO N/A
- WHWK N/A
- Revenue
- ALTO $933,137,000.00
- WHWK $21,596,000.00
- Revenue This Year
- ALTO N/A
- WHWK $49.83
- Revenue Next Year
- ALTO $7.68
- WHWK N/A
- P/E Ratio
- ALTO N/A
- WHWK N/A
- Revenue Growth
- ALTO N/A
- WHWK N/A
- 52 Week Low
- ALTO $0.76
- WHWK $1.39
- 52 Week High
- ALTO $2.05
- WHWK $3.81
- Technical
- Relative Strength Index (RSI)
- ALTO 47.82
- WHWK 49.43
- Support Level
- ALTO $0.99
- WHWK $1.60
- Resistance Level
- ALTO $1.10
- WHWK $1.69
- Average True Range (ATR)
- ALTO 0.06
- WHWK 0.09
- MACD
- ALTO 0.00
- WHWK 0.00
- Stochastic Oscillator
- ALTO 69.23
- WHWK 62.96
About ALTO Alto Ingredients Inc.
Alto Ingredients Inc is a producer of specialty alcohols and essential ingredients. The company serves five markets: Health, Home and Beauty, Food and Beverage, Essential Ingredients, and Renewable Fuels. Its customers include food and beverage companies and consumer products manufacturers and distributors. The company operates under three segments: Marketing and distribution, Pekin Campus production, Western production, and Others.
About WHWK Whitehawk Therapeutics Inc. Common Stock
Whitehawk Therapeutics Inc is a preclinical stage oncology therapeutics. The company is engaged in applying technologies to established tumor biology to efficiently deliver improved cancer treatments. The company's three-asset ADC portfolio is engineered to overcome the limitations of first-generation predecessors to deliver a meaningful impact for patients with difficult-to-treat cancers.